128 related articles for article (PubMed ID: 36917412)
21. The eternal enigma in prostatic biopsy access route.
Fabiani A; Principi E; Filosa A; Servi L
Arch Ital Urol Androl; 2017 Oct; 89(3):245-246. PubMed ID: 28969413
[TBL] [Abstract][Full Text] [Related]
22. Clinical outcome of transrectal ultrasound-guided prostate biopsy, targeting eight cores, for detecting prostate cancer in Japanese men.
Ishimura T; Sakai I; Hara I; Eto H; Miyake H
Int J Clin Oncol; 2004 Feb; 9(1):47-50. PubMed ID: 15162826
[TBL] [Abstract][Full Text] [Related]
23. Comparison of contrast-enhanced ultrasound targeted biopsies versus standard systematic biopsies for prostate cancer correction in different PSA value groups in rural China.
Lu DY; Liu L; Shen L; Cai JR; Xu L; Xiang LH
Clin Hemorheol Microcirc; 2021; 77(3):295-301. PubMed ID: 33252065
[TBL] [Abstract][Full Text] [Related]
24. Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.
Gallina A; Maccagnano C; Suardi N; Capitanio U; Abdollah F; Raber M; Salonia A; Scattoni V; Rigatti P; Montorsi F; Briganti A
BJU Int; 2012 Jul; 110(2 Pt 2):E64-8. PubMed ID: 22093108
[TBL] [Abstract][Full Text] [Related]
25. Prostate cancer diagnosis: should patients with prostate specific antigen >10ng/mL have stratified prostate biopsy protocols?
Philip J; Manikandan R; Javlé P; Foster CS
Cancer Detect Prev; 2009; 32(4):314-8. PubMed ID: 19193497
[TBL] [Abstract][Full Text] [Related]
26. Does the addition of targeted prostate biopsies to standard systemic biopsies influence treatment management for radiation oncologists?
Kamrava M; Hegde JV; Abgaryan N; Chang E; Le JD; Wang J; Kupelian PA; Marks LS
BJU Int; 2016 Apr; 117(4):584-91. PubMed ID: 25684394
[TBL] [Abstract][Full Text] [Related]
27. Systematic and MRI-Cognitive Targeted Transperineal Prostate Biopsy Accuracy in Detecting Clinically Significant Prostate Cancer after Previous Negative Biopsy and Persisting Suspicion of Malignancy.
Vėželis A; Platkevičius G; Kinčius M; Gumbys L; Naruševičiūtė I; Briedienė R; Petroška D; Ulys A; Jankevičius F
Medicina (Kaunas); 2021 Jan; 57(1):. PubMed ID: 33435132
[No Abstract] [Full Text] [Related]
28. Is extended 11-core biopsy valuable in benign prostatic hyperplasia patients with intermediate serum prostate-specific antigen (4.1-10 ng/ml) and prior negative sextant biopsy?
Abdel-Khalek M; El-Baz M; Ibrahiem el-H
Scand J Urol Nephrol; 2004; 38(4):315-20. PubMed ID: 15669591
[TBL] [Abstract][Full Text] [Related]
29. Impact of additional sampling in the TRUS-guided biopsy for the diagnosis of prostate cancer.
Stamatiou K; Alevizos A; Karanasiou V; Mariolis A; Mihas C; Papathanasiou M; Bovis K; Sofras F
Urol Int; 2007; 78(4):313-7. PubMed ID: 17495488
[TBL] [Abstract][Full Text] [Related]
30. Increasing prostate-specific antigen levels differently influence prostate cancer detection rates of two different 12-core prostate biopsy schemes.
Lodeta B; Benko G; Trkulja V
Urol Int; 2013; 91(1):75-80. PubMed ID: 23614932
[TBL] [Abstract][Full Text] [Related]
31. Improved prostate cancer detection using systematic 14-core biopsy for large prostate glands with normal digital rectal examination findings.
Inahara M; Suzuki H; Kojima S; Komiya A; Fukasawa S; Imamoto T; Naya Y; Ichikawa T
Urology; 2006 Oct; 68(4):815-9. PubMed ID: 17070359
[TBL] [Abstract][Full Text] [Related]
32. Anterior prostate biopsy at initial and repeat evaluation: is it useful to detect significant prostate cancer?
Pepe P; Pennisi M; Fraggetta F
Int Braz J Urol; 2015; 41(5):844-8. PubMed ID: 26689509
[TBL] [Abstract][Full Text] [Related]
33. Can initial prostate specific antigen determinations eliminate the need for bone scans in patients with newly diagnosed prostate carcinoma? A multicenter retrospective study in Japan.
Kosuda S; Yoshimura I; Aizawa T; Koizumi K; Akakura K; Kuyama J; Ichihara K; Yonese J; Koizumi M; Nakashima J; Fujii H
Cancer; 2002 Feb; 94(4):964-72. PubMed ID: 11920464
[TBL] [Abstract][Full Text] [Related]
34. The value of a baseline bone scan in patients with newly diagnosed prostate cancer.
Lin K; Szabo Z; Chin BB; Civelek AC
Clin Nucl Med; 1999 Aug; 24(8):579-82. PubMed ID: 10439178
[TBL] [Abstract][Full Text] [Related]
35. Predicting the extent of prostate cancer using the combination of systematic biopsy and serum prostate-specific antigen in Japanese men.
Gohji K; Okamoto M; Takenaka A; Nomi M; Fujii A
BJU Int; 1999 Jan; 83(1):39-42. PubMed ID: 10233449
[TBL] [Abstract][Full Text] [Related]
36. The pursuit of prostate cancer in patients with a rising prostate-specific antigen and multiple negative transrectal ultrasound-guided prostate biopsies.
Pryor MB; Schellhammer PF
Clin Prostate Cancer; 2002 Dec; 1(3):172-6. PubMed ID: 15046692
[TBL] [Abstract][Full Text] [Related]
37. Fusion prostate biopsy outperforms 12-core systematic prostate biopsy in patients with prior negative systematic biopsy: A multi-institutional analysis.
Sidana A; Watson MJ; George AK; Rastinehad AR; Vourganti S; Rais-Bahrami S; Muthigi A; Maruf M; Gordetsky JB; Nix JW; Merino MJ; Turkbey B; Choyke PL; Wood BJ; Pinto PA
Urol Oncol; 2018 Jul; 36(7):341.e1-341.e7. PubMed ID: 29753548
[TBL] [Abstract][Full Text] [Related]
38. The sufficiency of 6 core sextant prostate biopsy in patients with prostate specific antigen (PSA) values over 20 ng/mL.
Yücel C; Budak S; Kısa E; Celik O; Kozacıoglu Z
Arch Ital Urol Androl; 2018 Jun; 90(2):104-106. PubMed ID: 29974721
[TBL] [Abstract][Full Text] [Related]
39. [Analysis of transrectal needle biopsy of the prostate: usefulness of systematic 12 core biopsy].
Imazu T; Yokoyama S; Fukuhara S; Hara T; Yamaguchi S; Adachi S
Hinyokika Kiyo; 2007 Jun; 53(6):365-8. PubMed ID: 17628932
[TBL] [Abstract][Full Text] [Related]
40. Prostate cancer detection rate of transrectal ultrasonography, digital rectal examination, and prostate-specific antigen: results of a five-year study of 6- versus 12-core transperineal prostate biopsy.
Bigliocchi M; Marini M; Nofroni I; Perugia G; Shahabadi H; Ciccariello M
Minerva Urol Nefrol; 2007 Dec; 59(4):395-402; 403-6. PubMed ID: 17947956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
